Strong inhibition of Ewing tumor xenograft growth by combination of human interferon-alpha or interferon-beta with ifosfamide (Q44194187)

30 November 2017

title

Strong inhibition of Ewing tumor xenograft growth by combination of human interferon-alpha or interferon-beta with ifosfamide (English)

1 reference

30 November 2017

1 reference

1 reference

Olivier Delattre

3

0 references

Xavier Sastre-Garau

object named as

Xavier Sastre-Garau

4

0 references

author name string

Josiane Sancéau

1

1 reference

30 November 2017

Marie-France Poupon

2

1 reference

30 November 2017

Juana Wietzerbin

5

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

30 November 2017

1 reference

30 November 2017

volume

21

1 reference

30 November 2017

issue

50

1 reference

30 November 2017

page(s)

7700-7709

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1205881

30 November 2017

exact match

0 references

cites work

DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205881

Interferons alpha and beta as immune regulators--a new look

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205881

Second-generation interferons for cancer: clinical targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205881

Effect of zidovudine therapy in patients with HIV infection on endogenous interferon plasma levels and the hepatic cytochrome P450 enzyme system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205881

Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205881

Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205881

Treatment of recurrent or progressive malignant glioma with a recombinant adenovirus expressing human interferon-beta (H5.010CMVhIFN-beta): a phase I trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205881

Low expression of bcl-2 in Brca1-associated breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205881

Regression of infancy hemangiomas with recombinant IFN-alpha 2b.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205881

How does interferon-alpha exert its antitumour activity in multiple myeloma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205881

Cytokine therapeutics: lessons from interferon alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205881

Beta-interferon and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205881

The state of the STATs: recent developments in the study of signal transduction to the nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205881

Hairy cell leukaemia: review of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205881

How effective is dose-intensive/myeloablative therapy against Ewing's sarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205881

The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205881

The Stat family in cytokine signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205881

Effect of human interferon beta gene transfer upon human glioma, transplanted into nude mouse brain, involves induced natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205881

Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma Study CESS 86.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205881

Treatment strategies for metastatic Ewing's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205881

Interferon-beta gene therapy inhibits tumor formation and causes regression of established tumors in immune-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205881

IFN-beta induces serine phosphorylation of Stat-1 in Ewing's sarcoma cells and mediates apoptosis via induction of IRF-1 and activation of caspase-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205881

How cells respond to interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205881

Interferons and the tumor cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205881

Interferon-alfa-based treatment of chronic myeloid leukemia and implications of signal transduction inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205881

Interferons in precancer and cancer prevention: where are we?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205881

All-trans retinoic acid and interferon-alpha in the treatment of a patient with resistant metastatic osteosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205881

Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205881

Treatment of stage II cutaneous T-cell lymphoma with interferon alfa-2a and extracorporeal photochemotherapy: a prospective controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205881

Interferon alpha-2a therapy in haemangiomas of infancy: spastic diplegia as a severe complication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205881

Differences in Activity between α and β Type I Interferons Explored by Mutational Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205881

Suppression of Cytochrome P450- and UDP Glucuronosyl Transferase-Dependent Enzyme Activities by Proinflammatory Cytokines and Possible Role of Nitric Oxide in Primary Cultures of Pig Hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205881

Ewing's family of tumors in adults: multivariate analysis of survival and long-term results of multimodality therapy in 182 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205881

7 January 2021

How does interferon exert its cell growth inhibitory effect?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205881

7 January 2021

p53 mutations in human tumors with chimericEWS/FLI/1 genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205881

7 January 2021

Suppression of angiogenesis and therapy of human colon cancer liver metastasis by systemic administration of interferon-alpha

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205881

7 January 2021

Italian Cooperative Study for the treatment of children and young adults with localized Ewing sarcoma of bone: a preliminary report of 6 years of experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205881

7 January 2021

Systemic IFN-beta gene therapy results in long-term survival in mice with established colorectal liver metastases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1205881

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1205881

1 reference

30 November 2017

1 reference